The blood glucose meter market is experiencing significant growth, driven by the rising prevalence of diabetes, technological advancements, and increasing awareness about self-monitoring of blood glucose levels.
The global blood glucose meter market size was valued at USD 7,419.0 million in 2018 and is projected to reach USD 15,415.6 million by 2026, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period. In 2018, North America led the market, accounting for a 40.61% share.
In June 2018, BioTel Care™ introduced a next-generation wireless blood glucose meter for diabetes management. It is the first FDA-cleared, cellular-enabled glucometer that supports real-time transmission and consolidation of patient data in an FDA-cleared cloud.